31 – 40 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
(
- Contribution to journal › Scientific review
-
Mark
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
(
- Contribution to journal › Article
-
Mark
Refinement of breast cancer molecular classification by miRNA expression profiles
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article